Table 1 Clinical assessments between pre- and post-treatments of autologous adipose tissue-derived mesenchymal stem cells (AdMSCs) in a patient with progressive supranuclear palsy (PSP) throughout the six months of follow-up
Day 0 | Month 1 | Month 3 | Month 6 | |
|---|---|---|---|---|
PSPRS (/Total 100 points) | 69 | 71 | 65 | 63 |
BBS (/Total 56 points) | 3 | 3 | 7 | 9 |
K-MMSE (/Total 30 points) | 15 | 14 | 19 | 17 |
MBI (/Total 100 points) | 7 | 9 | 15 | 21 |
Grip strength (Kg, R/L) | 8/8 | 1/8 | 9/18 | 8/10 |
BBT (Numbers, R/L) | 9/13 | 9/14 | 14/15 | 14/16 |
NHPT (Seconds, R/L) | 202/127 | 182/95 | 100/48 | 79/94 |